相关实验视频
Updated: Jan 16, 2026

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.9K
公开报告结果对血液细胞移植患者选择的影响
Christopher Strouse1, Mark Juckett2, Brent R Logan3,4
1Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA.
JCO oncology practice
|October 2, 2025
概括
血液细胞移植 (HCT) 结果的公开报告似乎并没有导致中心避免高风险患者. 分析显示,在中心收到低于预期的结果得分后,患者选择行为没有显著变化.
科学领域:
- 血液学 血液学 血液学
- 移植医学 移植医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 关于医疗保健结果的公开报告旨在提高质量,但可能会导致意想不到的后果.
- 患者选择中的风险厌恶是结果报告系统的潜在意外影响.
研究的目的:
- 调查血液细胞移植 (HCT) 结果的公开报告是否影响患者的选择行为.
- 确定是否有低于预期的结果的中心对高风险患者有偏见.
主要方法:
- 从2012年至2016年,每年使用中心特定的生存分析来评分美国HCT中心.
- 新低于预期的中心 (NBC) 与预测结果的控制中心进行了比较.
- 使用多变量模型分析了指数年之前和之后的患者群体特征.
主要成果:
- 在NBC和控制中心之间在八个特征之间没有发现患者选择的显著差异.
- 在NBC和对照之间预测的1年整体存活率的变化中没有统计学上显著的差异.
- 观察到的整体存活率在两组中都增加,变化没有显著差异.
结论:
- 评分低于预期结果的中心与一般患者选择趋势没有显著偏离.
- 美国公开报告HCT结果似乎不会引入针对高风险患者的意外偏见.
- 这些发现支持继续使用公开报告HCT结果,而不必担心偏见的患者选择.
更多相关视频
相关概念视频
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Tissue Transplantation
921
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
921
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K

